• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简明指南:巨细胞动脉炎的诊断与管理。

Concise guidance: diagnosis and management of polymyalgia rheumatica.

机构信息

Department of Rheumatology, Essex University Southend University Hospital, Westcliff-on-Sea, Essex.

出版信息

Clin Med (Lond). 2010 Jun;10(3):270-4. doi: 10.7861/clinmedicine.10-3-270.

DOI:10.7861/clinmedicine.10-3-270
PMID:20726461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5873556/
Abstract

Polymyalgia rheumatica (PMR) is among the most common reasons for long-term steroid prescription with great heterogeneity in presentation, response to steroids and disease course. The British Society for Rheumatology and the British Health Professionals in Rheumatology have recently published guidelines on management of PMR. The purpose of this concise guidance is to draw attention to the full guidelines and provide a safe and specific diagnostic process with advice on management and monitoring--specifically targeted at general practitioners, general physicians and rheumatologists.

摘要

巨细胞动脉炎(PMR)是长期使用类固醇药物的最常见原因之一,其临床表现、对类固醇的反应和疾病过程存在很大的异质性。英国风湿病学会和英国风湿病专业人员最近发布了 PMR 管理指南。本简明指南旨在引起对完整指南的关注,并提供安全且具体的诊断流程,以及有关管理和监测的建议——专门针对全科医生、普通内科医生和风湿病学家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcc/5873556/544643557127/clinmed-10-3-270fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcc/5873556/0daa5ee2dc7a/clinmed-10-3-270fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcc/5873556/544643557127/clinmed-10-3-270fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcc/5873556/0daa5ee2dc7a/clinmed-10-3-270fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcc/5873556/544643557127/clinmed-10-3-270fig2.jpg

相似文献

1
Concise guidance: diagnosis and management of polymyalgia rheumatica.简明指南:巨细胞动脉炎的诊断与管理。
Clin Med (Lond). 2010 Jun;10(3):270-4. doi: 10.7861/clinmedicine.10-3-270.
2
Polymyalgia rheumatica -- diagnosis and management.风湿性多肌痛——诊断与管理
Aust Fam Physician. 2011 May;40(5):303-6.
3
The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica.意大利风湿病学会肌痛性风湿症管理临床实践指南。
Reumatismo. 2020 Apr 10;72(1):1-15. doi: 10.4081/reumatismo.2020.1268.
4
BSR and BHPR guidelines for the management of polymyalgia rheumatica.英国风湿病学会(BSR)和英国国家医疗服务体系改善局(BHPR)关于风湿性多肌痛管理的指南。
Rheumatology (Oxford). 2010 Jan;49(1):186-90. doi: 10.1093/rheumatology/kep303a. Epub 2009 Nov 12.
5
Corticosteroids in polymyalgia rheumatica--a review of different treatment schedules.皮质类固醇在风湿性多肌痛中的应用——不同治疗方案综述
Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S56-7.
6
Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice.诊断和管理巨细胞动脉炎的挑战:英国普通实践中的多方法研究。
Br J Gen Pract. 2018 Nov;68(676):e783-e793. doi: 10.3399/bjgp18X699557.
7
Polymyalgia rheumatica: clinical update.风湿性多肌痛:临床进展
Aust Fam Physician. 2014 Jun;43(6):373-6.
8
[Treatment and diagnosis of polymyalgia rheumatica and temporal arteritis].[风湿性多肌痛和颞动脉炎的治疗与诊断]
Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3387.
9
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.全科医生和风湿病学家对巨细胞动脉炎现行管理实践的国际调查。
Rheumatology (Oxford). 2023 Aug 1;62(8):2797-2805. doi: 10.1093/rheumatology/keac713.
10
Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice.巨细胞动脉炎:全科医疗中的诊断、处方和监测。
Br J Gen Pract. 2013 May;63(610):e361-6. doi: 10.3399/bjgp13X667231.

引用本文的文献

1
Variability of Steroid Response Time in Polymyalgia Rheumatica: A Case Report.风湿性多肌痛中类固醇反应时间的变异性:一例报告。
Cureus. 2022 Nov 6;14(11):e31159. doi: 10.7759/cureus.31159. eCollection 2022 Nov.
2
An update on the general management approach to common vasculitides.常见血管炎的一般治疗方法的最新进展。
Clin Med (Lond). 2020 Nov;20(6):572-579. doi: 10.7861/clinmed.2020-0747.
3
Added value and cascade effects of inflammatory marker tests in UK primary care: a cohort study from the Clinical Practice Research Datalink.

本文引用的文献

1
BSR and BHPR guidelines for the management of polymyalgia rheumatica.英国风湿病学会(BSR)和英国国家医疗服务体系改善局(BHPR)关于风湿性多肌痛管理的指南。
Rheumatology (Oxford). 2010 Jan;49(1):186-90. doi: 10.1093/rheumatology/kep303a. Epub 2009 Nov 12.
2
Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.风湿性多肌痛第一年的临床结局、生活质量及诊断不确定性
Arthritis Rheum. 2007 Jun 15;57(5):803-9. doi: 10.1002/art.22777.
3
Polymyalgia rheumatica: the mess we are now in and what we need to do about it.
英国初级保健中炎症标志物检测的附加价值和级联效应:来自临床实践研究数据库的队列研究。
Br J Gen Pract. 2019 Jul;69(684):e470-e478. doi: 10.3399/bjgp19X704321. Epub 2019 Jun 17.
4
Use of multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to evaluate accuracy.在基层医疗中使用多种炎症标志物检测:利用临床实践研究数据库评估准确性。
Br J Gen Pract. 2019 Jul;69(684):e462-e469. doi: 10.3399/bjgp19X704309. Epub 2019 Jun 17.
5
A case report of polymyalgia rheumatica.一例风湿性多肌痛病例报告。
Reumatologia. 2018;56(3):190-193. doi: 10.5114/reum.2018.76906. Epub 2018 Jun 30.
6
Retrospective analysis of the clinical course of patients treated for polymyalgia.对接受多肌痛治疗患者临床病程的回顾性分析。
Open Access Rheumatol. 2013 Apr 24;5:33-41. doi: 10.2147/OARRR.S38443. eCollection 2013.
7
Balancing on the edge: implications of a UK national audit of the use of BSR-BHPR guidelines for the diagnosis and management of polymyalgia rheumatica.在边缘上平衡:英国国家审计对使用 BSR-BHPR 指南诊断和管理巨细胞动脉炎的影响。
RMD Open. 2015 Jul 28;1(1):e000095. doi: 10.1136/rmdopen-2015-000095. eCollection 2015.
风湿性多肌痛:我们目前所处的困境以及我们需要采取的应对措施。
Arthritis Rheum. 2006 Aug 15;55(4):518-20. doi: 10.1002/art.22106.
4
An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica.一项为期96周的双盲对照试验,比较长效甲基强的松龙与口服强的松龙治疗风湿性多肌痛的疗效。
Br J Rheumatol. 1998 Feb;37(2):189-95. doi: 10.1093/rheumatology/37.2.189.